The curious case of Wuhan’s Institute of Virology and remdesivir
Changes to China’s patent laws and a filing by a Wuhan lab involving Gilead’s remdesivir have set up an interesting patent race, says Thomas Moga of Dykema.
Latest biotechnology news
WHO urges vigilance against fake COVID-19 vaccines
29-03-2021
The World Health Organization has warned the public of the danger of counterfeit COVID-19 vaccines and urged people not to procure jabs outside of government channels.
Pyxis secures ADC licence from Pfizer
22-03-2021
Five minutes with… Penny Gilbert
09-03-2021
A deep dive into Regeneron v Kymab
08-03-2021
